{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:42:56Z","timestamp":1771731776533,"version":"3.50.1"},"publisher-location":"Cham","reference-count":46,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031631177","type":"print"},{"value":"9783031631184","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/82_2021_246","type":"book-chapter","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T15:04:40Z","timestamp":1642172680000},"page":"315-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Background, Role and Approach for Development of a Controlled Human Infection Model for Nontyphoidal Salmonella"],"prefix":"10.1007","author":[{"given":"Calman A.","family":"MacLennan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,28]]},"reference":[{"key":"246_CR1","doi-asserted-by":"crossref","unstructured":"Baliban SM et al (2018) Immunogenicity and induction of functional antibodies in rabbits immunized with a trivalent typhoid-invasive nontyphoidal Salmonella glycoconjugate formulation. Molecules 23:1749","DOI":"10.3390\/molecules23071749"},{"key":"246_CR2","unstructured":"Boston Consulting Group BC. Vaccines to tackle drug resistant infections. An evaluation of R&D opportunities 2018. Available https:\/\/vaccinesforamr.org\/wp-content\/uploads\/2018\/09\/Vaccines_for_AMR.pdf [Accessed 13 Sept 2021]"},{"key":"246_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1128\/CVI.00115-14","volume":"21","author":"MA Boyd","year":"2014","unstructured":"Boyd MA et al (2014) Serum bactericidal assays to evaluate typhoidal and nontyphoidal Salmonella vaccines. Clin Vaccine Immunol 21:712\u2013721","journal-title":"Clin Vaccine Immunol"},{"key":"246_CR4","doi-asserted-by":"crossref","unstructured":"Darton TC et al (2016) Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with Placebo and Ty21a PLoS Negl Trop Dis 10:e0004926","DOI":"10.1371\/journal.pntd.0004926"},{"key":"246_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/infdis\/jiy501","volume":"219","author":"R de Alwis","year":"2019","unstructured":"de Alwis R et al (2019) The role of maternally acquired antibody in providing protective immunity against nontyphoidal Salmonella in urban Vietnamese infants: a birth cohort study. J Infect Dis 219:295\u2013304","journal-title":"J Infect Dis"},{"key":"246_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/cix042","volume":"64","author":"HC Dobinson","year":"2017","unstructured":"Dobinson HC et al (2017) Evaluation of the clinical and microbiological response to Salmonella paratyphi A infection in the first paratyphoid human challenge model. Clin Infect Dis 64:1066\u20131073","journal-title":"Clin Infect Dis"},{"key":"246_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3644","volume":"48","author":"NA Feasey","year":"2016","unstructured":"Feasey NA et al (2016) Distinct Salmonella Enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings. Nat Genet 48:1211\u20131217","journal-title":"Nat Genet"},{"key":"246_CR8","doi-asserted-by":"crossref","unstructured":"GBD 2019 (2020) Diseases and injuries collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204\u20131222","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"246_CR9","unstructured":"Giersing B et al (2019) A year in review 2018\u20132019 WHO PDVAC meeting 26\u201328 June 2019. Available https:\/\/cdn.who.int\/media\/docs\/default-source\/immunization\/pdvac\/pdvac-2019\/day-2-2019-pdvac-presentation-(1).pdf?sfvrsn=6ba7e99c_5&download=true [Accessed 13 Sept 2021]"},{"key":"246_CR10","doi-asserted-by":"crossref","unstructured":"Gilchrist JJ, MacLennan CA (2019) Invasive nontyphoidal Salmonella disease in Africa. EcoSal Plus 8. https:\/\/doi.org\/10.1128\/ecosalplus.ESP-0007-2018","DOI":"10.1128\/ecosalplus.esp-0007-2018"},{"key":"246_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nri3858","volume":"15","author":"JJ Gilchrist","year":"2015","unstructured":"Gilchrist JJ et al (2015) Genetic susceptibility to invasive Salmonella disease. Nat Rev Immunol 15:452\u2013463","journal-title":"Nat Rev Immunol"},{"key":"246_CR12","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1073\/pnas.0910497107","volume":"107","author":"EN Gondwe","year":"2010","unstructured":"Gondwe EN et al (2010) Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci USA 107:3070\u20133075","journal-title":"Proc Natl Acad Sci USA"},{"key":"246_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1097\/00002030-200208160-00009","volume":"16","author":"MA Gordon","year":"2002","unstructured":"Gordon MA et al (2002) Non-typhoidal Salmonella bacteraemia among HIV-infected Malawian adults: high mortality and frequent recrudescence. AIDS 16:1633\u20131641","journal-title":"AIDS"},{"key":"246_CR14","doi-asserted-by":"crossref","unstructured":"Hindle Z et al (2002) Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers. Infect Immun 70:3457\u201367","DOI":"10.1128\/IAI.70.7.3457-3467.2002"},{"key":"246_CR15","doi-asserted-by":"crossref","unstructured":"Hohmann EL (2001) Nontyphoidal Salmonellosis Clin Infect Dis 32:263\u2013269","DOI":"10.1086\/318457"},{"key":"246_CR16","doi-asserted-by":"crossref","unstructured":"Jin C et al (2017) Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella typhi: a randomised controlled, phase 2b trial. Lancet 390:2472\u20132480","DOI":"10.1016\/S0140-6736(17)32149-9"},{"key":"246_CR17","doi-asserted-by":"publisher","first-page":"S596","DOI":"10.1093\/cid\/ciz909","volume":"69","author":"RW Kaminski","year":"2019","unstructured":"Kaminski RW et al (2019) Consensus report on Shigella controlled human infection model: immunological assays. Clin Infect Dis 69:S596\u2013S601","journal-title":"Clin Infect Dis"},{"key":"246_CR18","doi-asserted-by":"crossref","unstructured":"Kariuki S, Onsare RS (2015) Epidemiology and genomics of invasive nontyphoidal Salmonella infections in Kenya. Clin Infect Dis 61 Suppl 4:S317\u201324","DOI":"10.1093\/cid\/civ711"},{"issue":"Suppl 3","key":"246_CR19","doi-asserted-by":"publisher","first-page":"C21","DOI":"10.1016\/j.vaccine.2015.03.102","volume":"33","author":"S Kariuki","year":"2015","unstructured":"Kariuki S et al (2015) Antimicrobial resistance and management of invasive Salmonella disease. Vaccine 33(Suppl 3):C21\u2013C29","journal-title":"Vaccine"},{"key":"246_CR20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1101\/gr.091017.109","volume":"19","author":"RA Kingsley","year":"2009","unstructured":"Kingsley RA et al (2009) Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res 19:2279\u20132287","journal-title":"Genome Res"},{"key":"246_CR21","doi-asserted-by":"crossref","unstructured":"Lanzilao L et al (2015) Strain selection for generation of O-antigen-based glycoconjugate vaccines against invasive nontyphoidal Salmonella disease. PLoS One 10:e0139847","DOI":"10.1371\/journal.pone.0139847"},{"key":"246_CR22","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1073\/pnas.1111413109","volume":"109","author":"SJ Lee","year":"2012","unstructured":"Lee SJ et al (2012) Identification of a common immune signature in murine and human systemic Salmonellosis. Proc Natl Acad Sci USA 109:4998\u20135003","journal-title":"Proc Natl Acad Sci USA"},{"key":"246_CR23","doi-asserted-by":"crossref","unstructured":"MacLennan CA (2014) Antibodies and protection against invasive Salmonella disease. Front Immunol 5:635","DOI":"10.3389\/fimmu.2014.00635"},{"key":"246_CR24","doi-asserted-by":"crossref","unstructured":"MacLennan C et al (2004) Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 190:1755\u20131757","DOI":"10.1086\/425021"},{"key":"246_CR25","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1172\/JCI33998","volume":"118","author":"CA MacLennan","year":"2008","unstructured":"MacLennan CA et al (2008) The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children. J Clin Invest 118:1553\u20131562","journal-title":"J Clin Invest"},{"key":"246_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1126\/science.1180346","volume":"328","author":"CA MacLennan","year":"2010","unstructured":"MacLennan CA et al (2010) Dysregulated humoral immunity to nontyphoidal Salmonella in HIV-infected African adults. Science 328:508\u2013512","journal-title":"Science"},{"key":"246_CR27","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.4161\/hv.29054","volume":"10","author":"CA MacLennan","year":"2014","unstructured":"MacLennan CA et al (2014) Vaccines against invasive Salmonella disease: current status and future directions. Hum Vaccin Immunother 10:1478\u20131493","journal-title":"Hum Vaccin Immunother"},{"key":"246_CR28","doi-asserted-by":"crossref","unstructured":"MacLennan CA et al (2017) Presentation of life-threatening invasive nontyphoidal Salmonella disease in Malawian children: a prospective observational study. PLoS Negl Trop Dis 11:e0006027","DOI":"10.1371\/journal.pntd.0006027"},{"key":"246_CR29","doi-asserted-by":"publisher","first-page":"S577","DOI":"10.1093\/cid\/ciz886","volume":"69","author":"CA MacLennan","year":"2019","unstructured":"MacLennan CA et al (2019a) Consensus report on Shigella controlled human infection model: introduction and overview. Clin Infect Dis 69:S577\u2013S579","journal-title":"Clin Infect Dis"},{"key":"246_CR30","doi-asserted-by":"publisher","first-page":"S591","DOI":"10.1093\/cid\/ciz891","volume":"69","author":"CA MacLennan","year":"2019","unstructured":"MacLennan CA et al (2019b) Consensus report on Shigella controlled human infection model: clinical endpoints. Clin Infect Dis 69:S591\u2013S595","journal-title":"Clin Infect Dis"},{"key":"246_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1086\/650733","volume":"50","author":"SE Majowicz","year":"2010","unstructured":"Majowicz SE et al (2010) The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50:882\u2013889","journal-title":"Clin Infect Dis"},{"key":"246_CR32","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1128\/iai.61.9.3981-3984.1993","volume":"61","author":"P Mastroeni","year":"1993","unstructured":"Mastroeni P et al (1993) Adoptive transfer of immunity to oral challenge with virulent salmonellae in innately susceptible BALB\/c mice requires both immune serum and T cells. Infect Immun 61:3981\u20133984","journal-title":"Infect Immun"},{"key":"246_CR33","doi-asserted-by":"publisher","first-page":"10428","DOI":"10.1073\/pnas.1807655115","volume":"115","author":"F Micoli","year":"2018","unstructured":"Micoli F et al (2018) Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella. Proc Natl Acad Sci USA 115:10428\u201310433","journal-title":"Proc Natl Acad Sci USA"},{"key":"246_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1093\/infdis\/jiu045","volume":"210","author":"TS Nyirenda","year":"2014","unstructured":"Nyirenda TS et al (2014) Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children. J Infect Dis 210:56\u201364","journal-title":"J Infect Dis"},{"key":"246_CR35","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ng.2423","volume":"44","author":"CK Okoro","year":"2012","unstructured":"Okoro CK et al (2012) Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet 44:1215\u20131221","journal-title":"Nat Genet"},{"key":"246_CR36","doi-asserted-by":"crossref","unstructured":"Raffatellu M et al (2008) Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat Med 14:421\u2013428","DOI":"10.1038\/nm1743"},{"key":"246_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1473-3099(10)70072-4","volume":"10","author":"EA Reddy","year":"2010","unstructured":"Reddy EA et al (2010) Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect Dis 10:417\u2013432","journal-title":"Lancet Infect Dis"},{"key":"246_CR38","doi-asserted-by":"crossref","unstructured":"Salerno-Goncalves R et al (2002) Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine. J Immunol 169: 2196\u2013203.","DOI":"10.4049\/jimmunol.169.4.2196"},{"key":"246_CR39","doi-asserted-by":"crossref","unstructured":"Sandler NG, Douek DC (2012) Microbial translocation in HIV infection: causes, consequences and treatment opportunities. Nat Rev Microbiol 10:655\u2013666","DOI":"10.1038\/nrmicro2848"},{"key":"246_CR40","doi-asserted-by":"crossref","unstructured":"Shakya M et al (2019) Phase 3 efficacy analysis of a typhoid conjugate vaccine trial in Nepal. N Engl J Med 381:2209\u20132218","DOI":"10.1056\/NEJMoa1905047"},{"key":"246_CR41","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1371\/journal.pbio.0050244","volume":"5","author":"B Stecher","year":"2007","unstructured":"Stecher B et al (2007) Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177\u20132189","journal-title":"PLoS Biol"},{"key":"246_CR42","doi-asserted-by":"crossref","unstructured":"Still WL et al (2020) Surveillance for invasive Salmonella disease in Bamako, Mali, From 2002 to 2018. Clin Infect Dis 71:S130\u2013S140","DOI":"10.1093\/cid\/ciaa482"},{"key":"246_CR43","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.12688\/gatesopenres.13034.1","volume":"3","author":"L Stockdale","year":"2019","unstructured":"Stockdale L et al (2019) Cross-sectional study of IgG antibody levels to invasive nontyphoidal Salmonella LPS O-antigen with age in Uganda. Gates Open Res 3:1501","journal-title":"Gates Open Res"},{"key":"246_CR44","doi-asserted-by":"publisher","first-page":"S580","DOI":"10.1093\/cid\/ciz892","volume":"69","author":"KR Talaat","year":"2019","unstructured":"Talaat KR et al (2019) Consensus report on Shigella controlled human infection model: conduct of studies. Clin Infect Dis 69:S580\u2013S590","journal-title":"Clin Infect Dis"},{"key":"246_CR45","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1128\/CVI.00289-13","volume":"20","author":"E Trebicka","year":"2013","unstructured":"Trebicka E et al (2013) Role of antilipopolysaccharide antibodies in serum bactericidal activity against Salmonella enterica serovar Typhimurium in healthy adults and children in the United States. Clin Vaccine Immunol 20:1491\u20131498","journal-title":"Clin Vaccine Immunol"},{"key":"246_CR46","unstructured":"Williams VF et al (2017) Incidence of nontyphoidal Salmonella intestinal infections, active component, U.S. Armed Forces, 2007\u20132016. MSMR 24:6\u201310"}],"container-title":["Current Topics in Microbiology and Immunology","Human Challenge Studies for Vaccine Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2021_246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T12:02:11Z","timestamp":1729944131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2021_246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783031631177","9783031631184"],"references-count":46,"URL":"https:\/\/doi.org\/10.1007\/82_2021_246","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"28 December 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}